Shay Capital LLC - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 35 filers reported holding DIAMEDICA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Shay Capital LLC ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$20,000
-20.0%
10,0000.0%0.00%
+33.3%
Q1 2022$25,000
-32.4%
10,0000.0%0.00%
-50.0%
Q4 2021$37,000
-7.5%
10,0000.0%0.01%
+20.0%
Q3 2021$40,00010,0000.01%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
JACOB ASSET MANAGEMENT OF NEW YORK LLC 275,000$1,103,0000.40%
Manatuck Hill Partners, LLC 273,100$1,095,0000.38%
Stonepine Capital Management, LLC 165,775$665,0000.30%
Ikarian Capital, LLC 311,041$1,247,0000.09%
COOPERMAN LEON G 200,000$802,0000.04%
Jump Financial, LLC 18,300$73,0000.01%
Shay Capital LLC 10,000$40,0000.01%
Newbridge Financial Services Group, Inc. 1,510$6,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 30,904$124,0000.00%
Patriot Financial Group Insurance Agency, LLC 1,300$5,0000.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders